@AmpriusInc $AMPX is turning an EV battery line toward drones.
The headline: up to $75M in award funding.
Watch:
• Line conversion
• Milestone payments
• Customer orders
• Path to profit
AMPX reported Q2 revenue of $34M, up 126% YoY, but still posted a $5.1M net loss.
@NVIDIA added $150B to its buyback authorization, bringing remaining capacity to $235B.
Q2 FY27 revenue rose 106% YoY, with $21.3B in non-GAAP free cash flow.
Our 12+ month fundamental view is bullish.
Entry price and AI demand still matter. Buy, hold or wait?
GRAIL $GRAL is back in focus after a 7–2 FDA panel vote.
The panel found Galleri’s benefits outweigh its risks. But the vote is advisory. The FDA decision is still pending.
The bigger question: can favorable sentiment translate into approval, adoption and revenue growth?
Amazon × Generac. A potential $2.4B opportunity but the headline needs context.
The SEC filing points to expected initial deliveries across 2027–28.
What matters next:
• Shipments
• C&I margins
• Follow-on orders
Read the full breakdown from StockResearch.
#GNRC#Generac
4/ Our view at the Sep 24 close of $139.54: Neutral / watchlist. The full report tests contract conversion, dilution, and three-year scenarios. Read it on StockResearch: https://t.co/s4p0nwTarr
1/ Oracle’s cloud infrastructure revenue grew 121% in Q1 FY27. Demand is visible. The harder question: what remains for shareholders after funding the buildout?
3/ Removing only those specified advances produces a $16.8bn deficit after cash capex. That is a funding sensitivity, not normalized or GAAP cash flow. Do not also net the same advances against capex: that counts the benefit twice.
$CTAS raised its FY27 revenue guide to $12.15B–$12.27B.
Fiscal Q1 revenue grew 10.9% Y/Y, and GAAP operating margin rose to 23.6% from 22.7%.
Bullish 12+ month operating case, but entry price and the pending UniFirst deal matter.
#StockMarket#CTAS
$10,000 right now. What stock would you pick?
Explore the stock, run the analysis, and see what the data says before making a decision.
Follow StockResearch for more market research, stock analysis and predictive analytics.
#Micron#MU#StockAnalysis#Investing#StockResearch
$META rose 11.4% on Sept. 21 as Muse drew attention.
Can an AI agent turn users into paying subscribers?
Next two quarters: watch repeat usage, paid conversion and costs. Heavy spending and platform restrictions remain risks.
Promising catalyst. Entry price still matters.
The Fed hiked. Earnings must do the work.
Our weekly watchlist:
$NVDA — BUY
$VST — HOLD
$TMO — NO TRADE
@NVIDIA’s revenue reached $96.22B, but FCF fell to $21.34B from $48.55B sequentially.
The question now: can operating growth keep translating into cash?
@Broadcom’s fiscal Q3 2026 revenue grew 86%. The investor question: how much AI growth becomes cash per share?
We examine cash flow, contingent lease exposure and valuation.
Read the full research report on StockResearch:
https://t.co/2h4Be9GrDl
103 jets. Is $BA a buy?
@KoreanAir finalized its earlier commitment. No additional 103-jet order.
Non-GAAP FCF: +$631M in Q2 2026, but −$823M for H1, including Q2.
Watch cash flow + margins. Delivery delays remain a risk.
Swipe for our analysis.
Oil is rising. Inflation is sticky. The Fed is next. 👀
The market is getting more selective:
📉 S&P 500: -0.80%
📉 Russell 2000: -2.41%
📉 IGV: -2.92%
📈 SOXX: +1.39%
🛢️ USO: +9.12%
In this market, a big target gap isn't enough. Cash flow and execution still matter.